Knight Therapeutics Inc. (TSX: GUD)
5.73
+0.02 (0.35%)
Jul 19, 2024, 4:00 PM EDT
Knight Therapeutics Employees
Knight Therapeutics had 725 employees as of December 31, 2023. The number of employees increased by 27 or 3.87% compared to the previous year.
Employees
725
Change (1Y)
27
Growth (1Y)
3.87%
Revenue / Employee
458.22K CAD
Profits / Employee
-24.06K CAD
Market Cap
580.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Bausch + Lomb Corporation | 13,300 |
Curaleaf Holdings, Inc. | 5,650 |
Bausch Health Companies Inc. | 20,270 |
Tilray Brands, Inc. | 1,600 |
WELL Health Technologies Corp. | 1,507 |
Sienna Senior Living Inc. | 12,000 |
Canopy Growth Corporation | 1,029 |
Extendicare Inc. | 23,000 |
Knight Therapeutics News
- 2 months ago - Knight Therapeutics reports Q1 results - Seeking Alpha
- 2 months ago - Knight Therapeutics Reports First Quarter 2024 Results - GlobeNewsWire
- 2 months ago - Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America - GlobeNewsWire
- 2 months ago - Knight Therapeutics Inc. announces voting results from the Annual General Meeting - GlobeNewsWire
- 2 months ago - Notice of Knight Therapeutics’ First Quarter 2024 Results Conference Call - Financial Post
- 2 months ago - Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call - GlobeNewsWire
- 4 months ago - Knight Therapeutics Inc. (KHTRF) Q4 2023 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Knight Therapeutics GAAP EPS of -C$0.23, revenue of C$74.2M - Seeking Alpha